LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) is a company that should be getting more attention from investors and the just released annual results again proved that point. LGVN ...

The non-profit Hearts For Isabella was in the lead on efforts to raise more than $11,000 for a Belfast man, born with a rare ...

In 2024, the U.S. Food and Drug Administration (FDA) indicated that ELPIS II is a pivotal trial and, if it demonstrates sufficient evidence of efficacy, it would be acceptable for a Biologics License ...

Each year, approximately 40,000 babies are born in the United States with a congenital heart defect — that’s one child every ...

diagnosed with Hypoplastic Left Heart Syndrome (HLHS), a severe congenital heart defect where the left side of the heart is underdeveloped. The condition prevents his from pumping blood ...

diagnosed with Hypoplastic Left Heart Syndrome (HLHS), a severe congenital heart defect where the left side of the heart is underdeveloped. The condition prevents his from pumping blood effectively to ...

A devoted grandmother and her brother from Wakefield are taking on a sponsored skydive in memory of her first grandchild who tragically died from heart surgery complications at just under eight weeks ...

Megan Wild and Luciano Reynaga's son was born with a critical congenital heart defect. Maria Fareri Children's Hospital Babies born with hypoplastic left heart syndrome typically require multiple ...

a rare pediatric congenital heart birth defect in which the left ventricle ... evaluating Lomecel-B™ as a potential adjunct therapy for HLHS is currently enrolling 38 pediatric patients ...